| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and General Counsel | General Counsel | General Counsel
1 company
Michael Sardano is President and General Counsel at SRTS. Michael Sardano's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $496K at current prices.
Our model assigns Michael Sardano a middling insider score of 69/100, based on 8 past trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of +38.6%.
Net of sales, the SRTS filings show accumulation of 2,000 shares.
Michael Sardano has 19 Form 4 filings on record from January 2018 to December 2025, all as President and General Counsel at Sensus Healthcare (SRTS), 2018–2025.
The 21 reported transactions were 7 open-market purchases, 6 tax withholdings, 5 stock awards and 1 option exercise, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 7 purchases worth about $27K and 1 sale worth about $71K.
The largest open-market purchase was 1,000 shares of SRTS at an average $5.95 on February 10, 2025, about $6K. Twelve months later SRTS was down 19%.
The only open-market sale was 5,000 shares of SRTS at an average $14.13 on September 13, 2022, about $71K. Twelve months later SRTS was down 80%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | SRTS Sensus Healthcare, Inc. | President and General Counsel | Buy | 1,000 | $3.80 | $3,800.00 | +0.8% | -5.2% | - | |
| Nov 11, 2025 | SRTS Sensus Healthcare, Inc. | President and General Counsel | Buy | 1,000 | $4.26 | $4,260.00 | +0.9% | +16.6% | - | |
| Aug 13, 2025 | SRTS Sensus Healthcare, Inc. | President and General Counsel | Buy | 1,000 | $3.37 | $3,370.00 | +0.9% | +23.1% | -7.6% | |
| Feb 10, 2025 | SRTS Sensus Healthcare, Inc. | President and General Counsel | Buy | 1,000 | $5.95 | $5,950.00 | +0.9% | -25.0% | -19.1% | |
| Aug 28, 2023 | SRTS Sensus Healthcare, Inc. | President and General Counsel | Buy | 1,000 | $2.99 | $2,990.00 | +1.7% | -14.9% | +116.3% | |
| Aug 8, 2023 | SRTS Sensus Healthcare, Inc. | President and General Counsel | Buy | 1,000 | $3.78 | $3,777.80 | +1.8% | -42.7% | +51.4% | |
| May 8, 2023 | SRTS Sensus Healthcare, Inc. | President and General Counsel | Buy | 1,000 | $3.00 | $2,995.00 | +1.8% | +15.8% | +26.8% | |
| Sep 13, 2022 | SRTS Sensus Healthcare, Inc. | President and General Counsel | Sale+OE | 5,000 | $14.13 | $70,627.50 | -9.2% | -56.4% | -80.1% |